TITLE

Hepatitis C

AUTHOR(S)
Alper, Brian S.; Selius, Brian A.
PUB. DATE
July 2005
SOURCE
Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p59
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents an overview of hepatitis C. Number of people infected by hepatitis C; Etiology of hepatitis C virus; Prognosis of patient with hepatitis C virus infection.
ACCESSION #
17640794

 

Related Articles

  • ASK DR ANDREW. Gibson, Donna // Woman's Day (Australia Edition);2/21/2005, Vol. 57 Issue 8, p75 

    Provides information on the hepatitis C virus. Rate of the incidence of hepatitis among those infected by the virus; Ways to improve the chance of minimizing liver damage.

  • RISK FACTORS ASSOCIATED WITH HEPATITIS C VIRUS ACQUISITION IN A TERTIARY CARE SETTING. Ahmed, Ibrar; Ali, Zafar; Alam, Intekhab; Nazir, Sheikh Muhammad; Taqweem, Amjad; Mahboob, Amjad // Gomal Journal of Medical Sciences;Jan2011, Vol. 9 Issue 1, p32 

    Background: Hepatitis C is prevalent worldwide. In Pakistan HCV infection has prevalence of about 4-6%. This study was conducted to identify the risk factors associated with positive hepatitis C status in a tertiary care setting. Material & Methods: This was hospital-based descriptive study,...

  • Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Núñez, O.; Fernández-Martínez, A.; Majano, P. L.; Apolinario, A.; Gómez-Gonzalo, M.; Benedicto, I.; López-Cabrera, M.; Boscá, L.; Clemente, G.; García-Monzón, C.; Martín-Sanz, P. // Gut;Dec2004, Vol. 53 Issue 12, p1665 

    Background: Cyclooxygenase 2 (COX-2) and matrix metalloproteinases (MMPs) have been implicated in tissue injury and fibrogenesis in animal models but little is known regarding their role in hepatitis C virus (HCV) related liver disease in humans. Aims: To characterise the intrahepatic expression...

  • Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico. López-Colombo, Aurelio; Meléndez-Mena, Daniel; Sedeño-Monge, Virginia; Camacho-Hernández, Josó R.; Vázquez-Cruz, Eduardo; Morales-Hernández, Eduardo R.; Sosa-Jurado, Francisca; Márquez-Domínguez, Luis; Santos-López, Gerardo // Annals of Hepatology: Official Journal of the Mexican Associatio;Nov/Dec2014, Vol. 13 Issue 6, p746 

    Background. Approximately 180 million persons (~2.8%) globally are estimated to be infected by hepatitis C virus (HCV). HCV prevalence in Mexico has been estimated to be between 1.2 and 1.4%. The aim of present work was to determine the prevalence of HCV infection in patients and family members...

  • ASSOCIATION OF HEPATITIS C VIRUS INFECTION TO NON HODGKIN'S LYMPHOMA: IS THE VOLCANO NEAR TO BURST?: A CASE CONTROL STUDY. SHAIKH, BASHIR AHMED; MUHAMMAD, SHAIKH KHALID; GURBAKHSHANI, KOURO MAL // Medical Channel;Oct2011, Vol. 17 Issue 4, p25 

    Introduction & Objectives: Limited data is available on association of HCV infection and NHL in Pakistan. This was a matter of particular interest. So, this study was conducted to determine the association between HCV infection and NHL. Duration & Design: This 2 year observational, case control...

  • Desperately seeking hepatitis C virus. Moreno-Otero, Ricardo; Tarantino, Giovanni; Lakatos, Peter L.; Nakajima, Hisato // World Journal of Gastroenterology;5/14/2008, Vol. 14 Issue 18, p2946 

    Spanish investigators described recently the so-called occult hepatitis C virus (HCV) infection, emphasizing the detection of genomic and antigenomic HCV RNA strands in liver and peripheral blood mononuclear cells. Therefore, the persistence of viral replication in occult HCV infection should be...

  • Fibrosis progression in chronic hepatitis C virus infection. McCaughan, G. W.; George, J. // Gut;Mar2004, Vol. 53 Issue 3, p318 

    Chronic hepatitis C virus infection is typically characterised by slowly progressive hepatic fibrosis. However, it is recognised that some patients do not progress while others rapidly develop significant fibrosis. Here, we review studies that have assessed factors that could influence this rate...

  • Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy. Akram, Madiha; Idrees, Muhammad; Hussain, Abrar; Afzal, Samia; Ilyas, Muhammad; Zafar, Shamail; Aftab, Mahwish; Badar, Sadaf; Khubaib, Bushra // Virology Journal;2011, Vol. 8 Issue 1, p253 

    Background: Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment...

  • New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication. Ueda, Youki; Takeda, Midori; Mori, Kyoko; Dansako, Hiromichi; Wakita, Takaji; Kim, Hye-Sook; Sato, Akira; Wataya, Yusuke; Ikeda, Masanori; Kato, Nobuyuki // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics